Skip to main content
The EMBO Journal logoLink to The EMBO Journal
. 2014 Sep 17;33(21):2439–2441. doi: 10.15252/embj.201489886

Membrane tension drives ligand-independent integrin signaling

Ralph Thomas Böttcher 1, Reinhard Fässler 1,
PMCID: PMC4283401  PMID: 25230934

Abstract

Integrins anchor cells to the extracellular matrix (ECM) and control a multitude of essential cellular functions by activating a variety of signaling pathways. In this issue of The EMBO Journal, a study conducted by Ferraris and colleagues report that binding of urokinase-type plasminogen activator receptor (uPAR) to vitronectin is sufficient to trigger ligand-independent β1 and β3 integrin signaling. The coupling of uPAR and integrins occurs independent of lateral interaction between the two receptors, but relies on membrane tension (Ferraris et al, 2014).


See also: GMS Ferraris et al (November 2014)

Integrins require an activation step to switch from an inactive (low affinity) to an active (high affinity) state. The affinity switch is allosteric, affects the conformation of the entire molecule, and is induced upon binding of integrin activators (talins and kindlins) to β integrin cytoplasmic domains (Moser et al, 2009). The consequence of integrin activation is ligand binding and cell adhesion to the ECM and the assembly of a large molecular network that regulates multiple cellular processes crucial for development, physiology, and pathology (Legate et al, 2009).

When integrins are bound to ligand, they can be modulated through lateral associations with other membrane components, including diverse cell adhesion receptors (Woods & Couchman, 2000). One of these adhesion receptors is uPAR, which binds to distinct ligands including the urokinase-type plasminogen activator (uPA) and the extracellular matrix glycoprotein vitronectin (VN). uPAR is tethered to the plasma membrane with a glycosyl–phosphatidylinositol (GPI) anchor, lacks transmembrane and cytoplasmic domains, and therefore relies on transmembrane co-receptors for signal transduction. Although there is substantial evidence suggesting that integrins and other membrane proteins such as chemokine receptors and receptor tyrosine kinases (Liu et al, 2002; Resnati et al, 2002) serve as essential co-receptors for mediating uPAR signaling (Smith & Marshall, 2010), it is still unclear how uPAR and integrins interact functionally and whether a direct interaction or just proximity between the cell adhesion receptors is necessary to initiate signaling. Ferraris and colleagues report in this issue of The EMBO Journal that there is no need for a direct interaction between uPAR and integrins, but rather a requirement for a mechanical coupling of the two receptors through membrane tension leading to ligand-independent integrin signaling (Ferraris et al, 2014).

In an effort to shed light on the molecular mechanisms of uPAR-mediated signaling, Ferraris and colleagues seeded HEK293 cells expressing either wild-type uPAR (uPARwt) or vitronectin (VN)-binding deficient uPAR mutants (uPART54A and uPARW32A) onto VN (Ferraris et al, 2014). They found that uPAR-induced cell adhesion and spreading requires uPAR engagement with VN and that integrin-inhibitory antibodies blocked uPAR/VN-induced cell spreading and signaling. These findings confirm previous observations showing that integrins are crucial signal transducers downstream of uPAR/VN-induced cell adhesion (Wei et al, 1996; Madsen et al, 2007). Surprisingly, however, when Ferraris et al seeded their cells on a recombinant, integrin-binding-deficient VN variant (VNRAD), neither cell spreading nor p130Cas phosphorylation was affected (Ferraris et al, 2014), indicating that direct binding of integrins to VN was dispensable for uPAR/VN signaling. Moreover, when β1 integrins were inhibited with blocking antibodies uPAR/VNRAD signaling was abrogated, showing that unligated β1 integrins trigger downstream signaling pathways.

To determine how the uPAR/VN complex achieves ligand-independent integrin signaling, Ferraris and colleagues asked whether certain structural requirements of β1 integrin are required for this unusual receptor cross talk. They expressed a ligand binding defective β1 integrinD130A and found that it is only able to transduce uPAR-induced cell spreading on VNRAD when β1 integrin adopts an active conformation and permits talin and kindlin binding to its cytoplasmic domain (Ferraris et al, 2014). Thus, uPAR-induced β1 integrin signaling on VNRAD requires the active conformation of β1 integrin and the binding of integrin activators to integrin tails, but not binding of the integrin ectodomain to ligand.

To test whether induction of ligand-independent integrin signaling is specific to uPAR and dependent on a direct interaction between uPAR and integrins, Ferraris et al expressed structurally unrelated VN binding receptors as well as uPAR-variants tethered to the plasma membrane through the fusion of the uPAR ectodomain with unrelated GPI-anchors or transmembrane domains. They found that also a GPI-anchored PAI-1GPI, which binds VN but differs structurally from uPAR, as well as uPAR-variants with transmembrane tethers can trigger β1 integrin-dependent cell adhesion, spreading, and p130Cas phosphorylation when seeded on VNRAD. Interestingly, these integrin-dependent signaling outputs were also induced when uPAR-expressing cells were seeded on anti-uPAR antibody-coated surfaces, indicating that not even the uPAR ligand is necessary for signal induction. Furthermore, cells engineered to express a signaling-incompetent β3 integrin (β3Y2A) and seeded on anti-αVβ3 antibody-coated surfaces were still able to spread in a β1 integrin-dependent manner. Together, these experiments reveal that ligand-independent β1 integrin signaling requires integrin activation, which is induced by aggregating uPAR, through binding either to VN, αVβ3 or to an anti-uPAR antibody.

Figure 1.

Figure 1

Ligand-dependent and ligand-independent integrin signaling

Canonical integrin signaling requires active integrins binding to specific ligands in the ECM, the assembly of signaling and adaptor proteins at their cytoplasmic tails and the linkage to the actin cytoskeleton. Ligand-independent integrin signaling requires membrane tension generated by the uPAR/VN complex, an active integrin conformation and binding of integrin activators to the β integrin cytoplasmic tail. Whether the integrin-actin linkage is also required for ligand-independent integrin signaling has not been analyzed.

The authors also noted that induction of ligand-independent integrin signaling required immobilizing the uPAR ligand on a rigid substrate indicating a role of mechanosensing and mechanotransduction in the uPAR/VN signaling process. To more precisely define this functional association, they decided to investigate an involvement of membrane tension in uPAR/VN-integrin crosstalk by decreasing membrane tension with sucrose or deoxycholate (Ferraris et al, 2014). This treatment indeed strongly reduced cell spreading on VNRAD, but not on FN, indicating that the molecular mechanisms of ligand-dependent and ligand-independent integrin signaling differ with respect to the requirement for membrane tension.

Ferraris and colleagues show for the first time that the uPAR/VN signaling complex requires β1 or β3 integrins that do not have to bind ligand. Furthermore, they also show that membrane tension mechanically couples uPAR and integrins and that a direct interaction between uPAR and integrin is not needed for signaling. Although these findings are convincing, one should bear in mind that a direct interaction may well be functionally relevant in other circumstances, for example, for the uPAR-mediated recruitment of α5β1 integrins into lipid rafts (Grove et al, 2014).

The observations reported by Ferraris et al raise questions regarding the molecular mechanism and physiological relevance of this ligand-independent integrin signaling. The present study establishes uPAR-induced ligand-independent integrin signaling in cultured cells, which leaves open when ligand-dependent (canonical) and ligand-independent integrin signaling is used under physiological conditions, and to which extent the two modes of integrin signaling co-exist in an in vivo context. Furthermore, it will be important to know whether structural constrains to the receptor—ligand pair exist that are capable of inducing ligand-independent integrin signaling as the induction of ligand-independent integrin signaling is not restricted to uPAR/VN in their cell culture experiments. Another unanswered question is how integrins and talin become activated to induce signaling upon uPAR binding to VN. The current model of integrin signaling mandates that integrins and talins undergo a conformational change to induce signaling (Moser et al, 2009). It is possible that uPAR binding to VN could directly induce integrin activation as uPAR has been shown to regulate integrin function by inducing conformational changes in α5β1, αvβ3, and αMβ2 integrins (Smith & Marshall, 2010). Alternatively, uPAR could activate talin and kindlin or utilize integrins that are already in an active conformation. Finally, it would be interesting to know how ligand-dependent and ligand-independent integrin signaling differs in quantitative and qualitative terms. For example, the ligand-independent integrin signaling described by Ferraris and colleagues occurs independent of acto-myosin pulling forces exerted on integrins. Therefore, the size of integrin clusters should be small and the composition of the adhesome should be quantitatively and qualitatively different from conventional integrin-adhesive sites. Clearly, there is still a lot to do until this unusual integrin signaling is fully understood.

References

  1. Ferraris GMS, Schulte C, Buttiglione V, De Lorenzi V, Piontini A, Galluzzi M, Podesta A, Madsen CD, Sidenius N. The interaction between uPAR and vitronectin triggers ligand-independent adhesion signalling by integrins. EMBO J. 2014;33:2458–2472. doi: 10.15252/embj.201387611. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Grove LM, Southern BD, Jin TH, White KE, Paruchuri S, Harel E, Wei Y, Rahaman SO, Gladson CL, Ding Q, Craik CS, Chapman HA, Olman MA. Urokinase-type plasminogen activator receptor (uPAR) ligation induces a raft-localized integrin signaling switch that mediates the hypermotile phenotype of fibrotic fibroblasts. J Biol Chem. 2014;289:12791–12804. doi: 10.1074/jbc.M113.498576. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Legate KR, Wickström SA, Fässler R. Genetic and cell biological analysis of integrin outside-in signaling. Genes Dev. 2009;23:397–418. doi: 10.1101/gad.1758709. [DOI] [PubMed] [Google Scholar]
  4. Liu D, Aguirre Ghiso J, Estrada Y, Ossowski L. EGFR is a transducer of the urokinase receptor initiated signal that is required for in vivo growth of a human carcinoma. Cancer Cell. 2002;1:445–457. doi: 10.1016/s1535-6108(02)00072-7. [DOI] [PubMed] [Google Scholar]
  5. Madsen CD, Ferraris GMS, Andolfo A, Cunningham O, Sidenius N. uPAR-induced cell adhesion and migration: vitronectin provides the key. J Cell Biol. 2007;177:927–939. doi: 10.1083/jcb.200612058. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Moser M, Legate KR, Zent R, Fässler R. The tail of integrins, talin, and kindlins. Science. 2009;324:895–899. doi: 10.1126/science.1163865. [DOI] [PubMed] [Google Scholar]
  7. Resnati M, Pallavicini I, Wang JM, Oppenheim J, Serhan CN, Romano M, Blasi F. The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R. Proc Natl Acad Sci USA. 2002;99:1359–1364. doi: 10.1073/pnas.022652999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Smith HW, Marshall CJ. Regulation of cell signalling by uPAR. Nat Rev Mol Cell Biol. 2010;11:23–36. doi: 10.1038/nrm2821. [DOI] [PubMed] [Google Scholar]
  9. Wei Y, Lukashev M, Simon DI, Bodary SC, Rosenberg S, Doyle MV, Chapman HA. Regulation of integrin function by the urokinase receptor. Science. 1996;273:1551–1555. doi: 10.1126/science.273.5281.1551. [DOI] [PubMed] [Google Scholar]
  10. Woods A, Couchman JR. Integrin modulation by lateral association. J Biol Chem. 2000;275:24233–24236. doi: 10.1074/jbc.R000001200. [DOI] [PubMed] [Google Scholar]

Articles from The EMBO Journal are provided here courtesy of Nature Publishing Group

RESOURCES